期刊文献+

国产替罗非班对兔髂动脉损伤后血小板活化及血栓前状态的影响 被引量:1

Effects of tirofiban on activated-platelet and prethrombotic state in rabbit iliac artery injury models
下载PDF
导出
摘要 目的探讨国产替罗非班(欣维宁)对兔髂动脉急性损伤后血小板活化及血栓前状态的影响。方法健康、成年新西兰大白兔40只,实验前8~12h予阿司匹林12mg/kg、氯吡格雷16mg/kg灌胃后禁食。分成替罗非班预处理组(灌胃后即予替罗非班微泵维持至实验结束,Pre-T组)、替罗非班处理组(T组)和安慰剂组(c组)。动物麻醉后用球囊损伤右髂动脉,经静脉输注替罗非班或安慰剂至实验结束。术前、术后取血送检血小板聚集率,可溶性P选择素、6-酮-前列素F1a等血液指标。术中监测损伤处血压变化,部分行髂动脉造影,并制作病理切片,观察血栓形成情况及性质。结果共30只兔完成实验,其中Pre-T组11只,T组13只,c组6只。(1)血液指标:①可溶性P选择素:协方差分析表明,Pre-T组(术前58.1±26.2μg/L,术后53.2±40.2μg/L)与C组(术前29.7±13.7μg/L,术后62.7±22.4μg/L)或与T组(术前24.8±14.3μg/L,术后53.5±27;7μg/L)间手术前后可溶性P选择素水平变化的差异有统计学意义(P均〈0.05),而T组和C组间差异无统计学意义。②6-酮-前列素F1α:协方差分析结果表明,Pre-T组(术前116.2±11.0ng/L,术后104.8±13.5ng/L)与C组(术前109.1±14.6ng/L,术后70.7±20.5ng/L)或与T组(术前117.0±24.5ng/L,术后86.0±17.2ng/L)间手术前后6-酮-前列素F1α水平变化的差异有统计学意义(P均〈0.05),而T组和C组间差异无统计学意义。③血小板聚集率:Pre-T组(术前87.0%±11.6%,术后48.4%±7.7%)与C组(术前42.7%±15.3%,术后37.5%±28.8%)手术前后的变化之差异有统计学意义(P〈0.05),而T组与其他两组间未见显著差异。(2)局部血压变化:Pre-T组兔子右髂动脉的收缩压、舒张压无明显变化,而C组、T组则较术前均大幅度下降,但T组两者相等所需的时间有延长趋势。(3)血管造影及病理学:Pre-T组造影示血管通畅;虽也有血管壁损伤,但管腔内未见血栓形成。而T组、C组术中造影均可见血栓影;受损髂动脉均可见内皮细胞破坏和内弹性膜的撕裂,管腔内均形成巨大的“白色血栓”。结论替罗非班能有效地抑制血小板活化,改善血栓前状态,充分预处理获益更大。 Objective To investigate the effects of homemade tirofiban on activated-platelet and prethrombotic state in rabbit model of iliac artery injury by balloon angioplasty. Methods Forty New Zealand white rabbits, lavaged with aspirin ( 12 mg/kg) and clopidogrel(16mg/kg) 8 - 12hs before the experiment, followed by abrosia, were divided into 3 groups. The iliac artery injury models were set up successfully only in 30 out of the forty rabbits. Rabbits in the pre-treatment group ( n = 11 ) received homemade tirofiban right after being lavaged and the drug was given to the treatment group (n = 13 ) later after the lilac artery was injured by PTCA balloon. Placebo was given to the control (n =6) after the injury. Blood samples were drawn before and after the procedure for platelet aggregation, sP-selectin and 6-Keto- PGF1α analysis. Changes in iliac systolic blood pressure (SBP) and diastolic blood pressure (DBP) were monitored throughout the operation. Iliac arteriography and pathological study were carried out in some animals for analysis of the composition of thrombus. Results ( 1 ) The sP-selectin levels were different between the pre-treatment group and the treatment group ( 58. 1 + 26. 2 μg/L vs 24. 8 ± 14. 3 μg/L preoperation; 53. 2 ±40. 2 μg/L vs 53.5 ± 27. 7 μg/L pest-operation, respectively, P 〈 0. 05 ) ; as well as between the pre-treatment group and the control (29. 7 ± 13.7 μg/L pre-operation and 62. 7 ±22. 4 μg/L post-operation, P 〈 0.05 ). There were no differences in SP-selectin levels between the treatment group and the control through covariance analysis. (2) Differences were also found in 6-keto-PGF1α levels between the pre-treatment group and the treatment group ( 116. 2 ± 11.0 ng/L vs 117. 0 ± 24. 5 ng/L pre-operation and 104. 8 ± 13.5 ng/L vs 86. 0 ± 17.2 ng/L post operation, respectively, P 〈 0. 05 ) ; as well as between the pre-treatment group and the control ( 109. 1 ± 14. 6 ng/L pre-operation and 70. 7 ± 20. 5 ng/L postoperation, P 〈 0.05 ). No differences existed between the treatment group and the control. (3) No obvious changes in blood pressure were recorded in the pre-treatment group which dropped significantly in the treatment group and the control after the procedure. (4) Besides the pre-treatment group, thrombi were found both in the treatment group and the control under arteriography. Pathological study further revealed that the thrombi were mainly "white thrombi" and with severe endothelia injury of the iliac artery. Injury was also observed on the endothelia in the pre-treatment group under microscope but without thrombus formation. Conclusion Tirofiban can depress the progress of platelet activation and ameliorate the prethrombotic state. Pre-treatment with tirofiban may enhance thse benefits.
作者 朱建中 惠杰
出处 《中国介入心脏病学杂志》 2007年第1期37-40,共4页 Chinese Journal of Interventional Cardiology
关键词 血小板 血栓形成 替罗非班 “白色血栓” Platelet Thrombus Tirofiban
  • 相关文献

参考文献9

  • 1唐熠达,陈纪林,阮英茆,徐新林,王清峙,司文学,张连庄,杨跃进,高润霖,陈在嘉.不同剂量阿司匹林对兔动脉粥样硬化斑块进展的抑制作用[J].中华心血管病杂志,2003,31(8):609-612. 被引量:41
  • 2顾晴,陈纪林,阮英茆,司文学,王清峙,徐新林,褚雁,张连庄,陈在嘉.氯吡格雷对实验性动脉粥样硬化形成的影响[J].中国循环杂志,2004,19(2):145-148. 被引量:32
  • 3李春坚,黄峻,杨国平,徐以南,陆琳,冯振卿.球囊损伤致兔股动脉血栓形成模型[J].南京医科大学学报(自然科学版),2001,21(4):277-280. 被引量:16
  • 4Smith SC,Dove JT,Kern MJ,et al.ACC/AHA guidelines for percutaneous coronary intervention(revision of the 1993 PTCA guidelines) executive summary:a report of the American College of Cardiology/American Heart Association task force on practice guidelines(committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty).J Am Coll Cardiol,2001,37:2215-2238.
  • 5李春坚.重组葡激酶溶栓治疗的动物实验及临床研究.南京:南京医科大学,2001.
  • 6Davis MJ.Stability and instability two faces of coronary atherosclerosis the paul Dudley white lecture.Circulation,1996,94:2013-2020.
  • 7Isenberg WN,McEver RP,Phillips DR,et al.The platelet fibrinogen receptor:an immunogold-surface replica study of Agonist-induced ligand binding and receptor clustering.J Cell Biol,1987,104:1655.
  • 8McEver RP,Beckested JH,More KL,et al.GMP-140,a platelet granule membrane protein,is also synthesized by vascular endothelium cells and is localized in Weibel-palade bodies.J Clin Invest,1989,84:92-99,
  • 9吴国新,阮长耿.库血储存中血小板功能的变化[J].中华血液学杂志,1993,14(6):313-314. 被引量:10

二级参考文献32

  • 1蔡海江 高达.免疫性损伤对家兔实验性动脉粥样硬化的影响[J].中华心血管病杂志,1979,7:287-289.
  • 2Tangirala RK, Rubin EM, Palinski W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein Edeficient mice. J Lipid Res, 1995,36:2320-2328.
  • 3Lusis AJ. Atherosclerosis. Nature, 2000, 407:233-241.
  • 4Weintraub WS, Harrison DG. C-reactive protein, inflammation and atherosclerosis: do we really understand it yet? Eur Heart J, 2000, 21 : 958-960.
  • 5Belton O, Byrne D, Kearney D, et al. Cyclooxygenase-1 and - 2-dependent prostacyclin formation in patients with atherosclerosis. Circulation, 2000, 102: 840-845.
  • 6Paul A, Calleja L, Camps J, et al. The continuous asministration of aspirin attenuates atherosclerosis in apolipoprotein E-deficient mice. Life Sci, 2000, 68 :457-465.
  • 7Voisard R, Fisher R, Obwald M, et al. Aspirin (5mmol/L) inhibits leukocyte attack and triggered reactive cell proliferation in a 3D human coronary in vitro model. Circulation, 2001, 103:1688-1694.
  • 8Pratico D, Tillmann C, Zhang Z, et al. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. PNAS, 2001, 98:3358-3363.
  • 9Speir E, Zu-Xi Yu, Ferrans VJ, et al. Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Cir Res, 1998, 83: 210-216.
  • 10Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 2002, 324: 71-86.

共引文献95

同被引文献20

  • 1刘明,杨迅,陈晶,刘军利.不稳定型心绞痛患者血浆P-选择素、vWF的变化及意义[J].中原医刊,2005,32(16):27-27. 被引量:4
  • 2王振华,薛梅,殷惠军,陈可冀.血小板膜GPⅡb/Ⅲa活性与缺血性心脑血管疾病[J].中国临床康复,2006,10(48):142-144. 被引量:8
  • 3Paolo P , Pier GM. The humans platelet membrane glycoprotein Ⅱb/Ⅲa complex: a multifunctional adhesion receptor [ J I. Haematologiea, 2006, 77 ( 2 ) : 162-168.
  • 4Vinogradova O, Velyvis A, Velyviene A, et al. A structural mechanism of integrina Ⅱb/Ⅲa "Inside Out"activation as regulated by its cytoplasmic face[J].Cell,2002,110(5):587.
  • 5Hezard N, Metz D. Platelet activation in cardiology: methods, indicatians and therapeutic[J]. Mal Vasc,2006,24(4) :288-293.
  • 6Yusuf S, Mehta SR, Zhao F, et al. Early and late effects of clop idogrel in patients with acute coronary syndromes [ J ]. Circulation, 2003,107 (7) : 966-972.
  • 7Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of aplatelet glycoprotein receptor as an inherited risk factor for coronary thrombosis[J]. N Engl J Med, 2005,334 (17) : 12-13.
  • 8McEver RP, Beckested JH, More KL, et al. GMP2140, a platelet granulemembrahe protein is also synthesized by vascular endothelium cells and is localized in Weibepalade bodies[ J]. J Clin Invest, 2006,84( 1 ) : 92-99.
  • 9Frenette PS, Denis CV, Weiss L, et al. P-selectin glycoprotein ligand 1 ( PS- GL-1 ) is expressed on platelets and can mediate platelet endothelial enteractions invivo[J]. J Exp Med, 2000,191 : 141-142.
  • 10Cavusoglu E, Cheng J, Bhatt R, et al. Clopidogrel in the management of ischemic heart disease[J]. Heart Dis,2003,5(2):144-152.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部